2-101402633-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001145664.2(RFX8):c.1048G>T(p.Asp350Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000258 in 1,553,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145664.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFX8 | NM_001145664.2 | c.1048G>T | p.Asp350Tyr | missense_variant | 11/12 | ENST00000428343.6 | NP_001139136.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFX8 | ENST00000428343.6 | c.1048G>T | p.Asp350Tyr | missense_variant | 11/12 | 2 | NM_001145664.2 | ENSP00000401536.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000125 AC: 2AN: 160062Hom.: 0 AF XY: 0.0000118 AC XY: 1AN XY: 84520
GnomAD4 exome AF: 0.00000214 AC: 3AN: 1400792Hom.: 0 Cov.: 34 AF XY: 0.00000289 AC XY: 2AN XY: 690966
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.1048G>T (p.D350Y) alteration is located in exon 11 (coding exon 10) of the RFX8 gene. This alteration results from a G to T substitution at nucleotide position 1048, causing the aspartic acid (D) at amino acid position 350 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at